These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36453893)

  • 21. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.
    Harper L; Fumagalli GG; Barkhof F; Scheltens P; O'Brien JT; Bouwman F; Burton EJ; Rohrer JD; Fox NC; Ridgway GR; Schott JM
    Brain; 2016 Apr; 139(Pt 4):1211-25. PubMed ID: 26936938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular Lesions and Brain Atrophy in Alzheimer's, Vascular and Mixed Dementia: An Optimized 3T MRI Protocol Reveals Distinctive Radiological Profiles.
    Ramusino MC; Vitali P; Anzalone N; Melazzini L; Lombardo FP; Farina LM; Bernini S; Costa A
    Curr Alzheimer Res; 2022; 19(6):449-457. PubMed ID: 35726416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
    Inui Y; Ito K; Kato T;
    J Alzheimers Dis; 2017; 60(3):877-887. PubMed ID: 28922157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
    Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of 11C-Pittsburgh compound-B positron emission tomography in addition to magnetic resonance imaging and single-photon emission computed tomography on diagnosis of mild cognitive impairment to Alzheimer's disease.
    Kitajima K; Abe K; Takeda M; Yoshikawa H; Ohigashi M; Osugi K; Koyama H; Yamakado K
    Medicine (Baltimore); 2021 Jan; 100(3):e23969. PubMed ID: 33545981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease.
    Biasutti M; Dufour N; Ferroud C; Dab W; Temime L
    PLoS One; 2012; 7(4):e35559. PubMed ID: 22532859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T2 Relaxometry and Diffusion Tensor Indices of the Hippocampus and Entorhinal Cortex Improve Sensitivity and Specificity of MRI to Detect Amnestic Mild Cognitive Impairment and Alzheimer's Disease Dementia.
    Knight MJ; Wearn A; Coulthard E; Kauppinen RA
    J Magn Reson Imaging; 2019 Feb; 49(2):445-455. PubMed ID: 30209854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study protocol on Alzheimer's disease and related disorders: focus on clinical and imaging predictive markers in co-existing lesions.
    Boublay N; Fédérico D; Pesce A; Verny M; Blanc F; Paccalin M; Desmidt T; Grosmaître P; Moreaud O; Relland S; Bravant E; Bouet R; Krolak-Salmon P
    BMC Geriatr; 2018 Nov; 18(1):280. PubMed ID: 30428832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease.
    Malojcic B; Giannakopoulos P; Sorond FA; Azevedo E; Diomedi M; Oblak JP; Carraro N; Boban M; Olah L; Schreiber SJ; Pavlovic A; Garami Z; Bornstein NM; Rosengarten B
    BMC Med; 2017 Feb; 15(1):27. PubMed ID: 28178960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
    Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
    Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia.
    Bron EE; Steketee RM; Houston GC; Oliver RA; Achterberg HC; Loog M; van Swieten JC; Hammers A; Niessen WJ; Smits M; Klein S;
    Hum Brain Mapp; 2014 Sep; 35(9):4916-31. PubMed ID: 24700485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.
    de Mauléon A; Soto M; Kiyasova V; Delrieu J; Guignot I; Galtier S; Lilamand M; Cantet C; Lala F; Sastre N; Andrieu S; Pueyo M; Ousset PJ; Vellas B
    J Prev Alzheimers Dis; 2017; 4(3):183-193. PubMed ID: 29182709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
    Ingala S; van Maurik IS; Altomare D; Wurm R; Dicks E; van Schijndel RA; Zwan M; Bouwman F; Schoonenboom N; Boelaarts L; Roks G; van Marum R; van Harten B; van Uden I; Claus J; Wottschel V; Vrenken H; Wattjes MP; van der Flier WM; Barkhof F
    Eur Radiol; 2022 Nov; 32(11):7789-7799. PubMed ID: 35639148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.
    Chandra A; Dervenoulas G; Politis M;
    J Neurol; 2019 Jun; 266(6):1293-1302. PubMed ID: 30120563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
    Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW;
    Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Zhang S; Smailagic N; Hyde C; Noel-Storr AH; Takwoingi Y; McShane R; Feng J
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010386. PubMed ID: 25052054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI and cognitive scores complement each other to accurately predict Alzheimer's dementia 2 to 7 years before clinical onset.
    Zandifar A; Fonov VS; Ducharme S; Belleville S; Collins DL;
    Neuroimage Clin; 2020; 25():102121. PubMed ID: 31931400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.